Taufiqur Rahman Bhuiyan Selected Research

Cholera

2/2024	Cholera toxin and O-specific polysaccharide immune responses after oral cholera vaccination with Dukoral in different age groups of Bangladeshi participants.
1/2023	A snap-shot of a diarrheal epidemic in Dhaka due to enterotoxigenic Escherichia coli and Vibrio cholerae O1 in 2022.
1/2022	A non-inferiority trial comparing two killed, whole cell, oral cholera vaccines (Cholvax vs. Shanchol) in Dhaka, Bangladesh.
1/2022	Long-term sialidase-specific immune responses after natural infection with cholera: Findings from a longitudinal cohort study in Bangladesh.
10/2021	Systemic, Mucosal, and Memory Immune Responses following Cholera.
7/2021	Correction: Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh.
1/2021	Impact of Immunoglobulin Isotype and Epitope on the Functional Properties of Vibrio cholerae O-Specific Polysaccharide-Specific Monoclonal Antibodies.
1/2021	Vibrio cholerae Sialidase-Specific Immune Responses Are Associated with Protection against Cholera.
11/2020	Humans Surviving Cholera Develop Antibodies against Vibrio cholerae O-Specific Polysaccharide That Inhibit Pathogen Motility.
1/2020	Immunogenicity of a killed bivalent whole cell oral cholera vaccine in forcibly displaced Myanmar nationals in Cox's Bazar, Bangladesh.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Taufiqur Rahman Bhuiyan Research Topics

Disease

31	Cholera 02/2024 - 10/2005
27	Infections 10/2023 - 10/2005
10	Diarrhea 03/2024 - 12/2011
6	COVID-19 07/2023 - 01/2022
3	Convalescence 01/2023 - 08/2015
3	Typhoid Fever (Typhoid) 01/2019 - 11/2017
2	Coinfection 01/2023 - 01/2022
2	Malnutrition (Nutritional Deficiencies) 01/2021 - 01/2013
1	Poliomyelitis (Polio) 01/2023
1	Bacillary Dysentery (Shigellosis) 01/2023
1	Severe Acute Respiratory Syndrome 06/2022
1	Coronavirus Infections 03/2022
1	Parasitic Diseases (Parasitic Disease) 01/2022
1	Hepatitis E 12/2021
1	Dehydration (Water Stress) 01/2021
1	Reinfection 12/2019
1	Bacterial Infections (Bacterial Infection) 01/2019
1	Rotavirus Infections 11/2018
1	Communicable Diseases (Infectious Diseases) 12/2011

Drug/Important Bio-Agent (IBA)

19	AntigensIBA 01/2022 - 02/2009
17	VaccinesIBA 03/2024 - 10/2005
17	AntibodiesIBA 01/2023 - 02/2009
16	Immunoglobulin A (IgA)IBA 01/2023 - 02/2009
15	Immunoglobulin G (IgG)IBA 01/2023 - 02/2009
12	Cholera Vaccines FDA Link 02/2024 - 05/2009
10	O Antigens (O Antigen)IBA 02/2024 - 05/2014
10	LipopolysaccharidesIBA 01/2023 - 12/2011
8	Cholera ToxinIBA 02/2024 - 10/2013
8	Immunoglobulin M (IgM)IBA 03/2022 - 05/2014
5	Blood Group Antigens (Blood Groups)IBA 10/2021 - 02/2009
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2016
4	EnzymesIBA 01/2019 - 02/2009
3	Monoclonal AntibodiesIBA 01/2023 - 11/2020
3	Proteins (Proteins, Gene)FDA Link 04/2019 - 10/2013
3	ImmunosorbentsIBA 01/2019 - 02/2009
2	DukoralIBA 02/2024 - 10/2013
2	Neuraminidase (Sialidase)IBA 01/2022 - 01/2021
2	CD40 Ligand (CD40L)IBA 01/2022 - 04/2019
2	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 12/2010
2	MicronutrientsIBA 11/2016 - 01/2013
2	Polysaccharides (Glycans)IBA 01/2016 - 01/2015
1	AnticoagulantsIBA 07/2023
1	Enterotoxins (Enterotoxin)IBA 01/2023
1	Interleukin-17 (Interleukin 17)IBA 01/2023
1	Ferritins (Ferritin)IBA 01/2023
1	ProcalcitoninIBA 01/2023
1	C-Reactive ProteinIBA 01/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023
1	fibrin fragment D (D-dimer)IBA 01/2023
1	ChAdOx1 nCoV-19IBA 06/2022
1	shancholIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Lipopolysaccharide ReceptorsIBA 01/2021
1	Ion Channels (Ion Channel)IBA 11/2020
1	SaltsIBA 11/2020
1	IntegrinsIBA 12/2019
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2019
1	Rotavirus VaccinesIBA 11/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018
1	InterferonsIBA 01/2018
1	HLA-DR Antigens (HLA-DR)IBA 01/2018
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2018
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	Dual OxidasesIBA 01/2018
1	RIX4414 vaccineIBA 01/2018
1	cholera vaccine CVD 103-HgRIBA 01/2018
1	Interferon Regulatory Factor-7 (Interferon Regulatory Factor 7)IBA 01/2018
1	Hemolysin Proteins (Hemolysins)IBA 11/2017
1	LeptinIBA 08/2015
1	Conjugate VaccinesIBA 01/2015
1	Tetanus ToxinIBA 01/2015
1	squaric acidIBA 01/2015
1	CytokinesIBA 08/2012
1	ABO Blood-Group SystemIBA 12/2011
1	Lewis Blood Group AntigensIBA 12/2011
1	Indicators and Reagents (Reagents)IBA 10/2005

Therapy/Procedure

1	Fluid Therapy (Oral Rehydration Therapy) 01/2018